[HTML][HTML] COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance

A Achar, C Ghosh - Cells, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human
coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID …

[HTML][HTML] Complement in neurological disorders and emerging complement-targeted therapeutics

MC Dalakas, H Alexopoulos, PJ Spaeth - Nature Reviews Neurology, 2020 - nature.com
The complement system consists of a network of plasma and membrane proteins that
modulate tissue homeostasis and contribute to immune surveillance by interacting with the …

[HTML][HTML] Physiology of gangliosides and the role of antiganglioside antibodies in human diseases

G Cutillo, AH Saariaho, S Meri - Cellular & molecular immunology, 2020 - nature.com
Gangliosides are structurally and functionally polymorphic sialic acid containing
glycosphingolipids that are widely distributed in the human body. They play important roles …

[HTML][HTML] Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype?

D Endres, TA Pollak, K Bechter, D Denzel… - Translational …, 2022 - nature.com
Obsessive-compulsive disorder (OCD) is a highly disabling mental illness that can be
divided into frequent primary and rarer organic secondary forms. Its association with …

[HTML][HTML] Systematic review: syndromes, early diagnosis, and treatment in autoimmune encephalitis

C Hermetter, F Fazekas, S Hochmeister - Frontiers in neurology, 2018 - frontiersin.org
In recent years, new antibodies have been discovered which mediate autoimmune
encephalitis. This immunological response can be triggered by an infection or a tumor …

In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy

G Colasante, Y Qiu, L Massimino, C Di Berardino… - Brain, 2020 - academic.oup.com
Epilepsy is a major health burden, calling for new mechanistic insights and therapies.
CRISPR-mediated gene editing shows promise to cure genetic pathologies, although …

[HTML][HTML] The landscape of novel therapeutics and challenges in glioblastoma multiforme: contemporary state and future directions

K Khaddour, TM Johanns, G Ansstas - Pharmaceuticals, 2020 - mdpi.com
Background: Glioblastoma multiforme is a malignant intracranial neoplasm that constitutes a
therapeutic challenge because of the associated high morbidity and mortality given the lack …

[HTML][HTML] Caveolin1 is required for Th1 cell infiltration, but not tight junction remodeling, at the blood-brain barrier in autoimmune neuroinflammation

SE Lutz, JR Smith, DH Kim, CVL Olson, K Ellefsen… - Cell reports, 2017 - cell.com
Lymphocytes cross vascular boundaries via either disrupted tight junctions (TJs) or caveolae
to induce tissue inflammation. In the CNS, Th17 lymphocytes cross the blood-brain barrier …

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets

TG Forsthuber, DM Cimbora… - Therapeutic …, 2018 - journals.sagepub.com
Increasing recognition of the role of B cells in the adaptive immune response makes B cells
an important therapeutic target in autoimmunity. Numerous current and developmental …

[HTML][HTML] Autoantibody biomarkers for basal ganglia encephalitis in sydenham chorea and pediatric autoimmune neuropsychiatric disorder associated with …

JL Chain, K Alvarez, A Mascaro-Blanco, S Reim… - Frontiers in …, 2020 - frontiersin.org
Movement, behavioral, and neuropsychiatric disorders in children have been linked to
infections and a group of anti-neuronal autoantibodies, implying dopamine receptor …